Bariatric Surgery Associates with Nonalcoholic Steatohepatitis/Hepatocellular Carcinoma Amelioration via SPP1 Suppression

Nonalcoholic steatohepatitis (NASH) is one of the most common chronic liver diseases worldwide and no effective drugs or treatments have been approved for disease management. Recently, bariatric surgery (BS) is considered to be a novel disease-modifying therapy for NASH and liver metabolic diseases,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuai, Tang, Liming, Guillot, Adrien, Liu, Hanyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867453/
https://www.ncbi.nlm.nih.gov/pubmed/36676937
http://dx.doi.org/10.3390/metabo13010011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867453/
https://www.ncbi.nlm.nih.gov/pubmed/36676937
http://dx.doi.org/10.3390/metabo13010011

Ejemplares similares